The plasmid vector platform is the most commonly used vector for the expression of the versatile CRISPR-Cas technique and the promoter is a crucial element for the expression vector, thus profiling the impact of the promoters on CRISPR editors provides the basic information for the gene-editing toolkits and can be a guideline for its design. Herein, we made a parallel comparison among four commonly used promoters (CAG,â~â1700Â bp; EF1a core,â~â210Â bp; CMV, ~â500Â bp; and PGK,â~â500Â bp) in CRISPR-Cas12a system in mammalian cells to explore the impact of promoters on this powerful tool. We found that without badly damaging targeting specificity, the CAG promoter-driving Cas12a editor exhibited the most active (efficiency takes as 100%, specificity indexâ=ââ~â75%) in genomic cleavage, multiplex editing, transcriptional activation, and base editing, followed by promoter CMV (efficiencyâ=â70â~â90% (vs CAG), specificity indexâ=ââ~â78%), and then EF1a core and PGK (both efficiencyâ=â40-60%, vs CAG) but with higher specificity (specificity indexâ=ââ~â84% andâ~â82%, respectively). Therefore, CAG is recommended in the CRISPR-Cas12a system for the applications that need a robust editing activity but without size limitation, CMV mostly can be an alternative for CAG when requiring a smaller space, EF1a is similar to PGK with relatively high specificity, but has a smaller size, thus is more suitable for in vivo therapeutic applications. The data outlined the properties of the widely used promoters in the CRISPR-Cas12a system, which can be a guide for its applications and can be a useful resource for the gene-editing field.
Profiling the impact of the promoters on CRISPR-Cas12a system in human cells.
分析启动子对人类细胞中 CRISPR-Cas12a 系统的影响。
阅读:9
作者:
| 期刊: | Cellular & Molecular Biology Letters | 影响因子: | 10.200 |
| 时间: | 2023 | 起止号: | 2023 May 17; 28(1):41 |
| doi: | 10.1186/s11658-023-00454-9 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
